Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brooks

Showing results (1151-1160 of 1,175) with videos related to

Pageof 118
Sort By:
The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
Cancers|June 19, 2024
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and OpportunitiesMeghan J Walker, Kristina M Blackmore, Amy Chang, et al.
Cell Reports. Medicine|January 20, 2024
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomasShiqin Liu, Timothy Chai, Fernando Garcia-Marques, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 14, 2025
Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: findings from PERSPECTIVE I&ILaurence Lambert-Côté, Annie Turgeon, Kristina M Blackmore, et al.
Clinical Breast Cancer|February 5, 2026
Canadian Women's Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I ProjectJennifer D Brooks, Kristina M Blackmore, Nguyet N M Ngo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
Genetic Epidemiology|March 20, 2024
Breast and bowel cancers diagnosed in people 'too young to have cancer': A blueprint for research using family and twin studiesJohn L Hopper, Shuai Li, Robert J MacInnis, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 18, 2014
Characterizing genetic variants for clinical actionErin M Ramos, Corina Din-Lovinescu, Jonathan S Berg, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Nature|January 24, 2020
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivoChristopher C Nixon, Maud Mavigner, Gavin C Sampey, et al.
Pageof 118

Showing results (1151-1160 of 1,175) with videos related to

Sort By:
Pageof 118
The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
Cancers|June 19, 2024
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and OpportunitiesMeghan J Walker, Kristina M Blackmore, Amy Chang, et al.
Cell Reports. Medicine|January 20, 2024
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomasShiqin Liu, Timothy Chai, Fernando Garcia-Marques, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 14, 2025
Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: findings from PERSPECTIVE I&ILaurence Lambert-Côté, Annie Turgeon, Kristina M Blackmore, et al.
Clinical Breast Cancer|February 5, 2026
Canadian Women's Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I ProjectJennifer D Brooks, Kristina M Blackmore, Nguyet N M Ngo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
Genetic Epidemiology|March 20, 2024
Breast and bowel cancers diagnosed in people 'too young to have cancer': A blueprint for research using family and twin studiesJohn L Hopper, Shuai Li, Robert J MacInnis, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 18, 2014
Characterizing genetic variants for clinical actionErin M Ramos, Corina Din-Lovinescu, Jonathan S Berg, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Nature|January 24, 2020
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivoChristopher C Nixon, Maud Mavigner, Gavin C Sampey, et al.
Pageof 118